Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
10.3390/antiox12020320
Saved in:
Main Authors: | Cheah, Irwin K, Tang, Richard MY, Wang, Xiaoyuan, Sachaphibulkij, Karishma, Chong, Suet Yen, Lim, Lina HK, Wang, Jiong-Wei, Halliwell, Barry |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Language: | English |
Published: |
MDPI
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239239 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
NA+/K+ ATPASE: A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF DOXORUBICIN-INDUCED CARDIOTOXICITY
by: LENG BIN
Published: (2024) -
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022) -
Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
by: Tan, VZZ, et al.
Published: (2021) -
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
by: Dionne, Francois, et al.
Published: (2022) -
Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice
by: Chua, C.C., et al.
Published: (2011)